Bernard H. Bochner

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.1Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Papers

Driven by 43 papers — median percentile 63. Top paper: “Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial”.

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.01485

N/A

3.3DataRank · unranked

100 citations

Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo +34 more

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma

British Journal of Cancer(2021)10.1038/s41416-020-01244-2

N/A

1.6DataRank · unranked

40 citations

Hikmat Al‐Ahmadie, Kenneth Seier, Christopher Tully, Ashley Marie Regazzi, Eugene J. Pietzak +15 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy

British Journal of Urology(2021)10.1111/bju.15428

N/A

0.951DataRank · unranked

25 citations

Emily Vertosick, Daniel D. Sjoberg, Nathan C. Wong, Chun Huang, Eugene J. Pietzak +10 more

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005

N/A

0.937DataRank · unranked

33 citations

Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue +25 more

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

The Journal of Urology(2023)10.1097/ju.0000000000003202

N/A

0.740DataRank · unranked

26 citations

Daniel D. Sjoberg, Lucas Nogueira, Andrew Tracey, Ricardo Alvim, Peter A. Reisz +16 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0.416DataRank · unranked

15 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomy

European Journal of Surgical Oncology(2022)10.1016/j.ejso.2022.02.023

N/A

0.373DataRank · unranked

11 citations

Amy L. Tin, Garrett M. Nash, Nicole Benfante, N. I. McNeil, Andrew J. Vickers +11 more

A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology

Tomography(2023)10.3390/tomography9060161

N/A

0.345DataRank · unranked

9 citations

Ramesh Paudyal, Amaresha Shridhar Konar, Peter S. LaViolette, Oğuz Akın, Vaios Hatzoglou +8 more

Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.07.007

N/A

0.330DataRank · unranked

8 citations

Christopher Gaffney, Sanaz Firouzi, Wesley Yip, Andreas Aulitzky, Eugene J. Pietzak +11 more

Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.440

N/A

0.312DataRank · unranked

7 citations

Jonathan Coleman, Nathan C. Wong, Daniel D. Sjoberg, Bernard H. Bochner, Guido Dalbagni +15 more

Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.567

N/A

0.241DataRank · unranked

4 citations

Manuel De Jesus Escano, Wesley Yip, Song Jiang, Gopa Iyer, Hikmat Al‐Ahmadie +6 more

Prospective health‐related quality of life in women undergoing radical cystectomy and urinary diversion

British Journal of Urology(2025)10.1111/bju.16821

Top 63%

0.218DataRank

Top 63%3 citations

Kelly R. Pekala, Amy L. Tin, Daniel D. Sjoberg, Benjamin Beech, Thomas M. Atkinson +6 more

Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.418

N/A

0.165DataRank · unranked

2 citations

Rania Sheikh, Aliya Khurram, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz +10 more

IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.30.526266

N/A

0DataRank · unranked

4 citations

Patrick Smith, Juan Carlos Angulo-Lozano, Daniel Ranti, Bernard H. Bochner, John P. Sfakianos +4 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4614

N/A

0DataRank · unranked

0 citations

Christopher Gaffney, Christian Hernández, Patricia Morán, Kara Worth, Melissa McCarter +9 more

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Modern Pathology(2024)10.1016/j.modpat.2024.100557

N/A

0DataRank · unranked

17 citations

Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar +21 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0DataRank · unranked

4 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.10.016

N/A

0DataRank · unranked

0 citations

Christian Dagher, Olga T. Filippova, Qin Zhou, Alexia Iasonos, Nadeem R. Abu-Rustum +8 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0DataRank · unranked

22 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort

European Urology(2025)10.1016/j.eururo.2025.08.012

N/A

0DataRank · unranked

8 citations

Melissa Assel, Gopa Iyer, Scot A. Niglio, Bernard H. Bochner, Guido Dalbagni +28 more

Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.04.006

N/A

0DataRank · unranked

3 citations

Emily Vertosick, Neeta D’Souza, Nicole Benfante, Andrew T. Lenis, Peter A. Reisz +14 more

Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit

The Journal of Urology(2025)10.1097/ju.0000000000004387

N/A

0DataRank · unranked

5 citations

Emily Vertosick, Syed M. Alam, Fady Baky, S. Machele Donat, Eugene J. Pietzak +6 more

Patterns of Outpatient Urinalysis Testing and the Detection of Microscopic Hematuria

Urology(2025)10.1016/j.urology.2025.07.004

N/A

0DataRank · unranked

1 citations

Samuel Gold, Fady Baky, Andrew Nicholson, Eric Wahlstedt, Patrick R. Alba +10 more

Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis

European Urology Oncology(2020)10.1016/j.euo.2020.02.007

N/A

0DataRank · unranked

173 citations

Valeria Panebianco, Yoshifumi Narumi, Francesco Del Giudice, Valdair Francisco Muglia, Mitsuru Takeuchi +7 more

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.02.014

N/A

0DataRank · unranked

46 citations

Christopher Tully, Emily C. Zabor, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr +8 more

PD60-11 PROGNOSTIC SIGNIFICANCE OF PERIVESICAL LYMPH NODE STATUS IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY

The Journal of Urology(2020)10.1097/ju.0000000000000977.011

N/A

0DataRank · unranked

0 citations

Melissa Assel, Cristina Falavolti, Chun Huang, Nima Almassi, Shawn Dason +10 more

MP55-17 IS UROTHELIAL CARCINOMA WITH SARCOMATOID DIFFERENTIATION RESPONSIVE TO NEOADJUVANT CHEMOTHERAPY?

The Journal of Urology(2020)10.1097/ju.0000000000000924.017

N/A

0DataRank · unranked

0 citations

Emily Vertosick, Daniel D. Sjoberg, Eugene J. Pietzak, Eugene Cha, Timothy F. Donahue +5 more

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0205

N/A

0DataRank · unranked

53 citations

Kyle R. Roell, Markia A. Smith, Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley +15 more

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4526

N/A

0DataRank · unranked

5 citations

Jatin Gandhi, Min Yuen Teo, Michael Lattanzi, Samuel A. Funt, David H. Aggen +14 more

Genomic characterization of bladder cancer with variant histology.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.470

N/A

0DataRank · unranked

2 citations

Timothy N. Clinton, Wenhuo Hu, Nima Almassi, Peter A. Reisz, Hong Truong +12 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0DataRank · unranked

73 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy

British Journal of Urology(2022)10.1111/bju.15825

N/A

0DataRank · unranked

9 citations

Melissa Assel, Benjamin Beech, Nicole Benfante, Daniel D. Sjoberg, Adam Touijer +9 more

Neoadjuvant nivolumab (N) +/- ipilimumab (I) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.498

N/A

0DataRank · unranked

12 citations

Eugene J. Pietzak, Samantha Brown, Jie‐Fu Chen, Vanessa Peters, Ashley Marie Regazzi +15 more

Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.523

N/A

0DataRank · unranked

2 citations

Rania Sheikh, Yelena Kemel, Manuel De Jesus Escano, Aliya Khurram, Peter A. Reisz +15 more

Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4616

N/A

0DataRank · unranked

1 citations

David A. Knorr, Karissa Whiting, Venkatraman Seshan, Eugene J. Pietzak, Timothy F. Donahue +10 more

Defining innate immune training potential as a predictor of Bacillus Calmette-Guérin immunotherapy response in nonmuscle-invasive bladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.522

N/A

0DataRank · unranked

0 citations

Gil Redelman‐Sidi, Eugene J. Pietzak, Bernard H. Bochner, Michael S. Glickman, Song Jiang

Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies

Cancers(2023)10.3390/cancers15225468

N/A

0DataRank · unranked

18 citations

Alfonso Lema-Dopico, Ramesh Paudyal, Amaresha Shridhar Konar, Thomas L. Chenevert, Dariya Malyarenko +8 more

Association of smoking history on health-related quality of life in patients undergoing radical cystecomy

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2022.12.009

N/A

0DataRank · unranked

3 citations

Alexander D. Doudt, Daniel D. Sjoberg, Matthew Clements, Amy L. Tin, Thomas M. Atkinson +6 more

Bernard H. Bochner

Indexed papers

Top data-sharing exemplar

Papers